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Apoptosis, a form of cell death that is coordinated by a set
of defined biochemical pathways, exists throughout the
animal kingdom. Its critically important roles in develop-
ment, homeostasis, and disease have made this a topic of
intensive research and sometimes even more intensive
controversy. One of these areas of controversy concerns
the role of ceramide, produced by the hydrolysis of sphin-
gomyelin. In this issue, Tepper et al. (2000) add to this de-
bate with an interesting new theory.
When we consider the central mechanisms of apoptosis,
we have two general questions to ask: first, what deter-
mines whether a cell will live or die? And if a cell is to
die, what determines the precise form of this cell death?
The second question is often as important as the first, as
we’ll see.
Evidence from early experiments showed that ceramide
is produced under a variety of conditions leading to apop-
tosis (Kolesnick and Kronke, 1998). The knowledge that
synthetic ceramide was able to induce apoptosis, led to the
unfortunately too simple conclusion that the production
and action of ceramide is an obligatory step in the apop-
totic process. Therefore, several studies (based predomi-
nantly on correlations) put forth the idea that sphingomy-
elin hydrolysis and signaling via ceramide are essential in
 
the decision of whether a cell dies.
 
 
 
This conclusion fell
from favor as evidence accumulated against ceramide pro-
duction as a major determinant of the life/death decision.
Now, a new study by Tepper and colleagues in this issue
(Tepper et al., 2000) has perhaps defined a new role for
sphingomyelin hydrolysis in apoptosis, determining not
whether but how a cell dies.
To understand this role in the context of the apoptotic
process (as it is currently understood), we will first review
the process itself and examine the different roles that have
been proposed for sphingomyelin hydrolysis in the differ-
ent pathways to apoptotic cell death.
When cells die via apoptosis, they undergo a number of
morphological and biochemical changes that are stereo-
typical for this type of death. These changes are orches-
trated by a set of cysteine proteinases that become active
during apoptosis, the caspases (cysteine proteinases with
specificity for aspartic acid residues; reviewed in Wolf and
Green, 1999). The final throes of cell death (and the asso-
ciated changes) have been named execution and the
caspases responsible for coordinating these changes are
the executioner caspases. Caspase-3 is the major execu-
tioner caspase, together with caspases-6 and -7.
The executioner caspases, once activated, cleave key
substrates in the cell that produce the apoptotic pheno-
type. For example, caspase-3 cleaves iCAD (inhibitor of
caspase-activated DNase), releasing CAD, which in turn
cuts the chromatin between nucleosomes to produce the
DNA ladder seen in many cell types as they undergo apop-
tosis. Another protein, acinus, is activated by caspase
cleavage to cause chromatin condensation. Similarly, cas-
pase-3 cleaves and activates p21-activated kinase-2 and
gelsolin, both of which appear to participate in contortions
of the plasma membrane, referred to as blebbing.
Other effects of the substrates of activated caspases are
inferred from the effects of caspase inhibitors or by the use
of cells lacking one or more caspases. These include loss of
mitochondrial membrane potential, cell shrinkage, loss of
cell adhesion, and loss of plasma membrane integrity,
among others.
One of the most important caspase-mediated changes in
the cell is the loss of plasma membrane lipid asymmetry.
That is, the lipids of the planar membrane are normally
nonrandomly distributed, some are predominantly local-
ized to one or the other side. For example, sphingomyelin
is mostly found on the outer leaflet, while phosphati-
dylserine and phosphatidylethanolamine are mostly on the
inner leaflet of the plasma membrane. This is due to the
action of phospholipid translocases that maintain the ori-
entations of some of the lipids (Bevers et al., 1999). During
apoptosis, the plasma membrane scrambles, and this in-
volves both loss of the translocase activity and the action
of an uncharacterized scramblase. Although this is often
(but not always, as I’ll discuss) caspase dependent, we do
not know the molecular mechanism of this event.
The loss of lipid asymmetry can be readily monitored by
the use of fluorescence-conjugated annexin V, which spe-
cifically binds to phosphatidylserine (PS)
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 as it external-
izes on apoptotic cells (Martin et al., 1995). The appear-
ance of PS on the outer leaflet of the plasma membrane is
especially relevant, because of all the changes we have so
far mentioned, it is the one with the most defined function.
PS is recognized and bound by a receptor (PSR) on mac-
rophages and other phagocytic cells, and this results in the
rapid clearance of the dying cell from the body (Fadok et
al., 2000). One could even argue that this is the only
change that a cell needs to go through to be functionally
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dead, since it will be phagocytosed and disposed of once
this has occurred. Binding of PSR influences the behavior
of the phagocyte as well, acting to ensure that the dead cell
is cleared without the induction of an inflammatory re-
sponse, an effect that stands in contrast to the conse-
quences of necrotic cell death.
Another biochemical change in the cell as it undergoes
apoptosis is, in many cases, the production of ceramide via
the hydrolysis of sphingomyelin, as mentioned above, and
this also seems to often be dependent on caspase activity.
Caspase inhibitors can block ceramide production during
apoptosis (Brenner et al., 1998; Boesen-de Cock et al., 1999),
and an intriguing reason for this has now been offered.
Tepper et al. (2000) propose
 
 
 
that as lipid asymmetry is lost
and sphingomyelin is brought into contact with the cyto-
sol, sphingomyelinases (mostly the uncharacterized neu-
tral sphingomyelinase, but acidic sphingomyelinase can
also be found in association with the inner leaflet of the
plasma membrane) act to hydrolyze it to phosphatidylcho-
line and ceramide. But here is where their model further
differs from that of other labs, they propose that it’s the
loss of sphingomyelin per se, and not the production of cer-
amide, that produces part of the apoptotic phenotype.
They show that as the sphingomyelin is lost from the mem-
brane, cholesterol (which is usually tightly associated with
it) is released, thus profoundly altering the fluidity of the
plasma membrane. In support of this, they show that cells
that fail to externalize PS during apoptosis do not produce
ceramide. Cells that do produce ceramide show more pro-
found blebbing and membrane release (Zhang et al., 1998)
that can be inhibited by addition of more sphingomyelin to
the membrane.
The proposed role for sphingomyelin hydrolysis is,
therefore, at the point that the fate of the cell is sealed. Is
this, then, the only role for sphingomyelin hydrolysis in
apoptosis? Perhaps, but to speculate about additional
roles we will have to extend our discussion of the apop-
totic process. So far, all of our discussion has focused on
the last stages of apoptosis, and the reader may have no-
ticed that no mention was made as to how the caspases be-
come active to orchestrate these events. The executioner
caspases reside as inactive zymogens in cells, and are acti-
vated by proteolytic cleavage, usually by another caspase.
But how does this get started? The key to this is the exist-
ence of another type of caspase, called initiator caspases,
which unlike the executioner caspases can be activated by
binding to adapter molecules via protein-protein interac-
tion domains (reviewed in Wolf and Green, 1999). Once
activated, the initiator caspases cleave and activate execu-
tioner caspases and the apoptotic execution proceeds.
The interactions of adapter molecules with initiator
caspases define two distinct (but often interconnected)
pathways of apoptosis. One of these involves so-called
death receptors which are a subset of the tumor necrosis
factor receptor family (including TNFR1, Fas/CD95, and
the TRAIL receptors, among others). Activation of a
death receptor recruits a complex of adapters and initiator
caspases to the intracellular region that results in the acti-
vation of the caspase at the plasma membrane (see Fig. 1).
The second pathway is the mitochondrial pathway. Pro-
apoptotic cell stimuli induce the activation of molecules in
the Bcl-2 family (which includes both pro- and anti-apop-
totic members; here we are concerned with the proapop-
totic members), which target the mitochondria and induce
the release of proteins that reside in the space between the
inner and outer mitochondrial membranes. One of these,
cytochrome c, catalyzes the activation of another adapter
protein, which binds and activates another initiator cas-
pase (see Fig. 1). Again, the activated initiator caspase
cleaves and activates the executioner caspases and death
proceeds. Much more detailed descriptions of these pro-
cesses can be found elsewhere (e.g., Green, 1998).
The anti-apoptotic members of the Bcl-2 family block
the release of cytochrome c from the mitochondria (e.g.,
Kluck et al., 1997) and also can inhibit ceramide produc-
tion in cells treated with DNA damaging agents (Tepper
et al., 1999), consistent with the model shown in Fig. 1.
Things get more confusing, however, when we look at the
effects of caspase inhibitors. Tepper et al. (2000) found
Figure 1. Apoptotic pathways leading to caspase activation, loss
of plasma membrane lipid asymmetry, and sphingomyelin hy-
drolysis. Two pathways for apoptosis are shown. In Pathway 1,
activation of death receptors, such as Fas/CD95, recruits a com-
plex composed of adapter molecules (FADD) and the proform
of an initiator caspase. This activates the caspase, which in turn
cleaves and activates executioner caspases. These, or possibly the
initiator caspase itself (see text) trigger scrambling of the plasma
membrane via an unknown mechanism. This brings sphingomy-
elin to the inner leaflet, where it is hydrolyzed by sphingomy-
elinases in the cell. This results in ceramide generation and in a
loss of sphingomyelin from the membrane. The latter, in turn,
causes a loss of cholesterol, which alters plasma membrane fluid-
ity. Ceramide may also perform signaling functions, although the
importance of this aspect is untested. In Pathway 2, cellular stress
(or other proapoptotic signals) trigger proapoptotic Bcl-2 family
members to target mitochondria and cause the release of cyto-
chrome c. The latter catalyzes the activation of adapter molecules
(Apaf-1) which recruit and activate initiator caspases. These, in
turn, cleave and activate executioner caspases. Again, the
caspases trigger lipid scrambling, sphingomyelin internalization
and hydrolysis, and the resultant membrane changes. 
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that although a pan-caspase inhibitor blocked ceramide
production as described previously (Brenner et al., 1998;
Boesen-de Cock et al., 1999), a slightly more specific and
less effective inhibitor could nevertheless separate PS ex-
ternalization and ceramide production from nuclear con-
densation, another caspase-dependent change in the cell.
 
Similarly, Grullich et al. (2000) found that induction of
ceramide by ectopic expression of FADD (a death recep-
tor associated adapter molecule) was caspase dependent
even under conditions where apoptosis did not proceed.
These results suggest that ceramide production (and per-
haps lipid scrambling leading to ceramide production) can
be a consequence of the action of an initiator caspase
rather than only executioner caspases.
If so, then the production of ceramide may still contrib-
ute to the ultimate demise of the cell. For example, cer-
amide has been shown to disrupt mitochondrial respira-
tion (Di Paola et al., 2000) which can be maintained even
after cytochrome c release (Goldstein et al., 2000). It is
also capable of blocking some anti-apoptotic mechanisms
involving Akt (Basu et al., 1998; Zhou et al., 1998) and this
too may ultimately contribute to apoptosis. If sphingomy-
elin hydrolysis happens at a sufficiently early point in the
pathway, therefore, the production of ceramide may influ-
ence either the rate and form of cell death or work to re-
lease blocks on downstream events.
Loss of lipid asymmetry is not unique to caspase-medi-
ated apoptosis. For example, a transient externalization of
PS can occur in response to calcium flux, and Tepper et al.
(2000) have shown that this can also result in ceramide
production. Whether this contributes to any apoptotic
pathways is an important question. Further, and intrigu-
ingly, membrane blebbing (McCarthy et al., 1997; Mills et
al., 1998) and PS externalization (Vanags et al., 1996) are
not always caspase dependent, even during apoptosis. We
might expect that in such cases, if these ideas are correct,
sphingomyelin hydrolysis and ceramide production will
proceed independently of caspase activation. If so, the
contribution of these effects to the life/death decision will
have to be considered.
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